The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
2SEVENTY BIO INC | COMMON STOCK | 901384107 | 8,721,000 | 855,000 | SH | DFND | 6 | 855,000 | 0 | 0 | |
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 3,125,250 | 135,000 | SH | DFND | 6 | 135,000 | 0 | 0 | |
COMPASS THERAPEUTICS INC | COM | 20454B104 | 9,253,158 | 2,829,712 | SH | DFND | 6 | 2,829,712 | 0 | 0 | |
CORVUS PHARMACEUTICALS INC | COM | 221015100 | 2,128,856 | 2,339,402 | SH | DFND | 6 | 2,339,402 | 0 | 0 | |
CULLINAN ONCOLOGY INC | COM | 230031106 | 34,264,977 | 3,349,460 | SH | DFND | 6 | 3,349,460 | 0 | 0 | |
ENTRADA THERAPEUTICS INC | COM | 29384C108 | 817,423 | 56,374 | SH | DFND | 6 | 56,374 | 0 | 0 | |
FREELINE THERAPEUTICS HLDGS | SPONSORED ADS | 35655L107 | 2,151,886 | 4,729,419 | SH | DFND | 6 | 4,729,419 | 0 | 0 | |
IKENA ONCOLOGY INC | COM | 45175G108 | 5,730,010 | 1,660,872 | SH | DFND | 6 | 1,660,872 | 0 | 0 | |
INOZYME PHARMA INC | COM | 45790W108 | 7,690,754 | 1,342,191 | SH | DFND | 6 | 1,342,191 | 0 | 0 | |
KEROS THERAPEUTICS INC | COM | 492327101 | 11,147,219 | 261,059 | SH | DFND | 6 | 261,059 | 0 | 0 | |
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 2,157,982 | 689,451 | SH | DFND | 6 | 689,451 | 0 | 0 | |
LARIMAR THERAPEUTICS INC | COM | 517125100 | 12,440,580 | 2,746,265 | SH | DFND | 6 | 2,746,265 | 0 | 0 | |
OMEGA THERAPEUTICS INC | COMMON STOCK | 68217N105 | 6,366,969 | 1,055,882 | SH | DFND | 6 | 1,055,882 | 0 | 0 | |
ONCORUS INC | COM | 68236R103 | 814,634 | 2,367,436 | SH | DFND | 6 | 2,367,436 | 0 | 0 | |
ORCHARD THERAPEUTICS PLC | SPON ADS NEW | 68570P200 | 4,219,414 | 785,738 | SH | DFND | 6 | 785,738 | 0 | 0 | |
OVID THERAPEUTICS INC | COM | 690469101 | 2,231,241 | 864,822 | SH | DFND | 6 | 864,822 | 0 | 0 | |
PLIANT THERAPEUTICS INC | COM | 729139105 | 79,848,812 | 3,001,835 | SH | DFND | 6 | 3,001,835 | 0 | 0 | |
PRECISION BIOSCIENCES INC | COM | 74019P108 | 2,614,857 | 3,469,820 | SH | DFND | 6 | 3,469,820 | 0 | 0 | |
PROMETHEUS BIOSCIENCES INC | COM | 74349U108 | 100,251,367 | 934,135 | SH | DFND | 6 | 934,135 | 0 | 0 | |
PROMETHEUS BIOSCIENCES INC | COM | 74349U108 | 108,125 | 25,000 | SH | Call | DFND | 6 | 25,000 | 0 | 0 |
RALLYBIO CORP | COM | 75120L100 | 4,342,701 | 760,543 | SH | DFND | 6 | 760,543 | 0 | 0 | |
REPARE THERAPEUTICS INC | COM | 760273102 | 29,499,719 | 2,997,939 | SH | DFND | 6 | 2,997,939 | 0 | 0 | |
SYROS PHARMACEUTICALS INC | COM NEW | 87184Q206 | 2,049,078 | 767,445 | SH | DFND | 6 | 767,445 | 0 | 0 | |
VECTIVBIO HLDG AG | ORD SHS | H9060V101 | 44,724,170 | 5,255,484 | SH | DFND | 6 | 5,255,484 | 0 | 0 |